Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study
In conclusion, the PMA, PNA, and IL-6 can be used as powerful diagnostic markers in ACS patients. Therefore, disrupting PMA and PNA formation and inhibiting cytokine production may be new strategies for the treatment of ACS. However, further investigations are required to explore these parameters in the clinical diagnosis of ACS.
Authors
- Keyvan Olazadeh (ORCID: https://orcid.org/0000-0003-2828-5805)
- Mohsen Hamidpour (ORCID: https://orcid.org/0000-0002-3658-1551)
- Davood Bashash (ORCID: https://orcid.org/0000-0002-8029-4920)
- Hojat Shahraki (ORCID: https://orcid.org/0009-0008-8466-9743)
- Somayeh Yazdanparast (ORCID: https://orcid.org/0000-0002-1744-4578)
- Mohammad Hossein Mohammadi (ORCID: https://orcid.org/0000-0002-8697-1371)
- Mohammad Ghorbani (ORCID: https://orcid.org/0000-0001-8829-4258)
- Mohamad Esmail Gheydari
- Nazli Atashzar
Institutions
- Tarbiat Modares University (IR)
- Gonabad University of Medical Sciences (IR)
- Research Institute for Endocrine Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Health Science Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/hsr2.70209
- Citations
- 4
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.96